Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Dyspnea: early-phase trial registry
7 of 24 indexed Dyspnea trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #686 of 28,707 conditions by registered trial count.
24 US clinical trials · 7 currently recruiting · #686 of 28,707 conditions by registered trial count
Dyspnea: 24 US clinical trials tracked, 7 recruiting.
Dyspnea is the subject of 24 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is M.D. Anderson Cancer Center, running 2 of these trials.
Enrollment posture brief
Registry condition dyspnea
OPEN 7 | RECR 29% | LATE 0 | EARLY 4 | RANK #686 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Bleeding (29% recruiting · 24 trials)
Dyspnea lists 7 open slots (29% of 24 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Dyspnea on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Dyspnea is recruiting below its size-band peers.
7 of 24 indexed trials (29.2%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Dyspnea trials is spread across many organizations.
M.D. Anderson Cancer Center accounts for 2 of 24 trials (8.3%). 23 distinct sponsors appear on at least one study for this condition label.
-
Typical Dyspnea enrolment sits around 73 participants.
Median target enrolment is 73 among the 24 trials that report a genuine target (sentinel values excluded). 14 of those (58.3%) plan for fewer than 100 participants.
-
Dyspnea research is mostly interventional.
17 interventional and 7 observational studies make up this index (70.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
24 total, page 1 of 1
Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology
M.D. Anderson Cancer Center
NCT06336642
Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
VA Office of Research and Development
NCT05937854
129Xe MRI Cardiopulmonary
Bastiaan Driehuys
NCT06038630
Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy
Ohio State University Comprehensive Cancer Center
NCT07386444
Cardiopulmonary Exercise Testing and Oscillometry for the Evaluation of Dyspnea
University of Rochester
NCT06554353
Ventilatory and Perfusion Abnormalities in Individuals With Post-Acute Sequelae of SARS-CoV-2 Infection
Tufts Medical Center
NCT05866952
The Increase of Lung Capacity Using the Lung Master (Pulmonary Exerciser)
University of Nebraska
NCT06524856
Improving Diagnostic Accuracy for Acute Heart Failure
Vanderbilt University Medical Center
NCT04886128
Dexamethasone in Controlling Dyspnea in Patients With Cancer
M.D. Anderson Cancer Center
NCT03367156
Breathlessness Relieved by Employing Medical Air to be Titrated by Hospitalized Patients to Improve Inpatient Experience
Ohio State University
NCT05416437
Improving Patient Prioritization During Hospital-homecare Transition
Columbia University
NCT04136951
Evaluation of Cardiopulmonary Diseases by Ultrasound
Echosense
NCT02248831
Emergency Department Cardiac Ultrasound
Hennepin Healthcare Research Institute
NCT02719509
Impact of Validated Diagnostic Prediction Model of Acute Heart Failure in the Emergency Department
Unity Health Toronto
NCT01193998
BRIPPED Scan for Evaluation of Emergency Department (ED) Patients With Shortness of Breath
Eastern Virginia Medical School
NCT01662843
Utility of Lung Clearance Index Score as a Noninvasive Marker of Deployment Lung Disease
National Jewish Health
NCT03012958
Precision of IMED-4 Lung Fluid Measurements
Intersection Medical
NCT02187770
Improving Management of Breathlessness in Patients With Lung Cancer
Massachusetts General Hospital
NCT01937637
Improving Care of Patients With Heart Failure
University of California, San Francisco
NCT01461681
Clinical Efficacy in Relief of Dyspnea by HVNI: Evaluation of New Cannulae Designs
Vapotherm
NCT04512781
Evaluation of Breathing Pattern and Dyspnea in Subjects With Tetraplegia
US Department of Veterans Affairs
NCT00904436
Oxygen Savings With Administered Oxygen and High Flow Ambient Air At Rest
Johns Hopkins University
NCT04170062
Device-guided Breathing for Shortness of Breath in COPD
Mayo Clinic
NCT01286181
Virtual Reality at End-of-life
State University of New York at Buffalo
NCT06149429
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on Dyspnea records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Dyspnea trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Dyspnea page
24 registered trials, 7 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 7 Dyspnea trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- M.D. Anderson Cancer Center sponsors the most Dyspnea trials on record, review their full trial history before evaluating a specific study. See M.D. Anderson Cancer Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Dyspnea condition card totals 24 registered trials; most-linked intervention Personalized virtual reality experience; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.